We tested the suspeptibility of Rickettsia conorii to ciprofloxacin, a new quinolone antibiotic. A final concentration of 1 ,ug/g of egg was effective in suppressing chicken embryo lethality, and a concentration of 0.25 ,g/ml inhibited plaque formation in a plaque assay; however, a concentration of 0.5 ,ug/ml was necessary to obtain rickettsiacidal activity. These results support the idea that ciprofloxacin could be of clinical use in treating Mediterranean spotted fever.
Tetracycline and chloramphenicol are the only antibiotics of clinical use in treating spotted-fever-group rickettsiosis. The purpose of this work was to evaluate the susceptibility of Rickettsia conorii to ciprofloxacin, a new quinolone antibiotic. Three methods were used: the reduction of chicken embryo lethality (5), the reduction of plaque formation (8) and, as proposed by McDade (4) , the application of a filter paper disk containing antibiotics to the agar overlay for the detection of a zone of inhibition of plaque formation.
MATERIALS AND METHODS Bacterial strain. R. conorii (ATCC VR 141) cultured on Vero cells (four passages) was used in this study. When dilution was necessary (plaque assay), the inoculum was diluted in Eagle minimal essential medium. The titer of the inoculum was determined by the plaque assay technique by determining the number of PFU per milliliter (6) .
Antibiotic. Ciprofloxacin monohydrate powder (concentration, 990 ,ug/mg, lot no. 9583 96; a gift from Bayer) was dissolved in distilled water to make a stock solution with a concentration of 1 mg/ml. The stock solution was diluted in Eagle minimal essential medium for the egg experiment and directly in the medium for the plaque assay. The filter paper disk had a 5-,ug concentration.
Eggs. "Antibiotic-free" embryonated eggs were obtained from the National Institute of Agronomic Research. Thirty chicken embryos, 5 days old, were injected in the yolk sac with 0.25 ml of the antibiotic solution to obtain a final concentration of 0 (positive control), 0.25, 0.5, 1, or 2 ,ug/g of egg. At 30 min later, R. conorii was inoculated into the yolk sac in a 0.25-ml volume containing 2,500 PFU. This sequence of introducing antibiotics is generally used (5) .
Five chicken embryos were injected with distilled water as a negative control.
In calculating the mean survival time, all embryos alive at the end of the experiment were considered to have died on day 13 (5).
Plaque assay. The plaque assay procedure used in this study was essentially the same as that described earlier (6) . Vero cell monolayers (24 h) in round plastic tissue culture * Corresponding author. disks (60 mm; Coming Glass Works) were infected with 1 ml of a solution containing 2,500 PFU and, after incubation (1 h at laboratory temperature), were overlaid with 5 ml of a medium containing Eagle minimal essential medium, 2% calf serum, 2% N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES), and 0.5% agar. The antibiotic stock solution was added to obtain a final concentration of 0 (positive control), 0.06, 0.125, 0.25, 0.5, 1, 2, or 4 ,ug/ml. In the disk assay, the disk was added when the agar was solid.
The monolayers were stained for photography by the addition of a second overlay containing Eagle minimal essential medium, 2% HEPES, 0.5% agar, and 0.01% neutral red after 3 days of incubation at 32°C in a CO2 incubator. Six experiments were done at each antibiotic concentration.
Rickettsiacidal activity. Eggs and Vero cells were harvested in case of survival. Smears from these samples were stained by the Gimenez technique (2) and by an indirect immunofluorescence technique with human anti-R. conorii serum revealed by a goat-conjugated antibody to human immunoglobulin.
RESULTS
Eggs. The mean survival time was 5.5 days in eggs receiving no antibiotics and in eggs receiving 0.25 ,ug of ciprofloxacin per g. It was 6.3 days in eggs receiving 0.5 jig of ciprofloxacin per g, 9.2 days in eggs receiving 1 ,ug/g, 11.3 days in eggs receiving 2 ,ug/g, and 10.8 days in the control group. The difference was not significant (variance analysis) among the positive control, 0.25-,u.g/g, and 0.5-,ig/g groups or between the 2-,ug/g and negative control groups. The difference was significant between the positive control and 1-xg/g groups (P < 0.05) and was very significant between the positive control and 2-jxg/g groups (P < 0.01). In the plaque assay, rickettsiae were observed in the 0.25-,ug/ml assay as well as in the 0.125-jig/ml and 0.06-,ug/ml assays. No rickettsiae were observed in the plaque assay at a ciprofloxacin concentration of 0.5 jig/ml. DISCUSSION Different methods are available for the determination of the antibiotic susceptibility of rickettsiae: the use of animals (guinea pigs), embryonated hen's eggs (5) , plaque assays (8) , or suppression of the cytopathic effect (1). Some discrepancies can occur among these methods because the first and second include host defense mechanisms. We used the two classical methods in this study. A final ciprofloxacin concentration of 1 jig/g of egg was efficient in suppressing chicken embryo lethality. The rickettsiacidal activity did not differ from the rickettsiostatic activity in the chicken embryo assay. This efficiency of ciprofloxacin can be compared with the efficiency of oxytetracycline (5) .
In the plaque assay, a final concentration of 0.25 jig/ml was enough to inhibit plaque formation. This concentration was rickettsiostatic but not rickettsiacidal. A concentration of 0.5 ,ug/ml was rickettsiacidal in the plaque assay. The diskassay, a simple, qualitative screening method introduced by McDade (4), demonstrated very clearly the efficiency of the compound. The rickettsiacidal concentration (0.5 jig/ml) is currently obtained with ciprofloxacin in humans after oral or parenteral administration (3).
In conclusion, this study, which is the first to evaluate the susceptibility of rickettsiae to a new quinolone compound, showed that R. conorii growth is inhibited by ciprofloxacin at a final concentration of 1 jig/ml. This result supports the idea that ciprofloxacin could be of clinical use in treating Mediterranean spotted fever.
